The global pharmaceutical industry's premier event, CPHI China International Pharmaceutical Ingredients Exhibition, will open its doors in Shanghai from June 24-26, 2025. Shandong Chenghui Pharmaceutical Group cordially invites you to visit Booth W1A30 to explore cutting-edge innovations and technical services.

Rooted in Shandong Province, Chenghui Pharmaceutical Group upholds the core values of "integrity-first, open collaboration, and innovation-driven," specializing in pharmaceutical ingredients, advanced intermediates, MAH, CDMO, veterinary medicine, and health products.
Established in 2014, its subsidiary Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. is a $500 million international production base focusing on high-end APIs and intermediates. The 200-acre facility in Dezhou Plain Economic Development Zone features:
6 GMP-compliant production workshops with 10 production lines
cGMP-standard R&D platforms and quality control centers
Annual capacity exceeding 1,000 tons, meeting international certification requirements.

Featured areas: local anesthetics, oncology, cardiovascular, antiviral, and gastrointestinal therapeutics, presenting novel APIs, green synthesis technologies, and customized CDMO solutions.
✅ Expert Consultation
Technical specialists and business representatives will provide one-on-one support for process optimization and regulatory compliance.
✅ Industry Insights
Engage in concurrent events to discuss pharmaceutical trends with Chenghui's team.

Packaging equipment and lab instruments (linked with PMEC China exhibits).
As a pivotal platform for industry exchange, Chenghui looks forward to connecting at Booth W1A30 to co-create opportunities in global healthcare.
June 24-26, 2025 | Shanghai New International Expo Centre | See you there!